Endoscopic resection of the prostate is a well defined surgical proced
ure. Nevertheless, certain coagulation disorders (hypercoagulability w
ith risk of deep vein thrombosis, haemorrhage) can raise special probl
ems. In patients not given heparin prophylaxis, the incidence of deep
vein thrombosis is 10% in transurethral resections of the prostate (TU
RF). The risk is higher for cancer. Among the diagnostic tools (D-dime
r assay, continuous Doppler, pulsed echo-Doppler, thermography, plethy
smography, ...) ascending phlebography or plumonary angiography in cas
e of suspected pulmonary emboli remains the gold standard. Haemorrhage
is rarely related to defribination but frequently to dilution coagulo
pathy favoured by high blood pressure, resorption of irrigation fluid,
deficient haemostasis with loss of coagulation factors or massive tra
nsfusions. Only clinically patent coagulation disorders leading to hae
morrhage should be treated. For dilution coagulopathies and diffuse in
travascular coagulation, treatment is based on viro-inactived fresh pl
asma infusion. Aprotinine is the first choice in case of fibrinolysis